Integra Lifesciences Holdings Corp share price logo

Integra Lifesciences Holdings Corp Share Price

NASDAQ: IART

Small Cap

$14.81

-0.02

(-0.13%)

as on

Integra Lifesciences Holdings Corp Stock Performance

as on September 18, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $14.76
    $15.69
    downward going graph

    0.34%

    Downside

    5.94%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $11.06
    $27.13
    downward going graph

    25.32%

    Downside

    83.19%

    Upside

    downward going graph

Integra Lifesciences Holdings Corp share price movements today

Previous Close
$14.83
Open
$14.80
Volume
823.4K
Day's Low - High
$14.76 - $15.69
52 Week Low - High
$11.06 - $27.13

Integra Lifesciences Holdings Corp Historical Returns

1 Month Return
+ 4.51 %
3 Month Return
+ 22.06 %
1 Year Return
-13.58 %
3 Year Return
-67.44 %
5 Year Return
-68.14 %

Integra Lifesciences Holdings Corp Stock Fundamentals & Key Indicators

Check Integra Lifesciences Holdings Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.2B

EPS (TTM)

2.2125

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

67.94

Industry PE ratio

-3.9281873111782475

P/B Ratio

0

PEG Ratio

0.7566

EBITDA

305.8M

Revenue (TTM)

1.6B

Profit Margin

-30.87%

Return On Equity TTM

316088100.00%

Integra Lifesciences Holdings Corp Stock Valuation

Track how Integra Lifesciences Holdings Corp P/E has moved over time to understand its valuation trends.

Integra Lifesciences Holdings Corp in the last 5 years

  • Overview

  • Trends

Lowest (8.53x)

December 31, 2024

Industry (-3.93x)

September 17, 2025

Today (67.94x)

September 17, 2025

Highest (25.47x)

March 31, 2021

LowHigh

Today’s Price to Earnings Ratio: 67.94x

Integra Lifesciences Holdings Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Integra Lifesciences Holdings Corp with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$1.2B-68.14%67.94-30.87%
BUY$146.7B149.51%58.9213.55%
BUY$144.0B78.01%50.0212.25%
BUY$231.1B24.47%16.6632.43%
BUY$120.8B-12.63%26.0213.63%

Stock Returns calculator for Integra Lifesciences Holdings Corp Stock including INR - Dollar returns

The Integra Lifesciences Holdings Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Integra Lifesciences Holdings Corp investment value today

Current value as on today

₹90,904

Returns

₹9,096

(-9.1%)

Returns from Integra Lifesciences Holdings Corp Stock

₹13,695 (-13.69%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Integra Lifesciences Holdings Corp Stock

Based on 20 analysts

BUY

50.00%

Buy

35.00%

Hold

15.00%

Sell

Based on 20 analysts, 50% of analysts recommend a 'BUY' rating for Integra Lifesciences Holdings Corp. Average target price of $15.88

Integra Lifesciences Holdings Corp Share Price Target

Get share price movements and forecasts by analysts on Integra Lifesciences Holdings Corp.

What analysts predicted

6.74%UPSIDE

Target Price

$15.88

Current Price

$14.81

Analyzed by

20 Analysts

Target

$15.88

Integra Lifesciences Holdings Corp target price $15.88, a slight upside of 6.74% compared to current price of $14.81. According to 20 analysts rating.

Integra Lifesciences Holdings Corp Stock's Interest Amongst Investors

Search interest for Integra Lifesciences Holdings Corp Stock has increased by 100% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:100% versus previous 30 day period

Integra Lifesciences Holdings Corp Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
380
381
382
397
368
418
380
442
382
415
Gross Profit
232
207
218
233
206
232
200
249
194
209
Operating Income
36
12
26
55
3
35
-8
35
-15
-512
EBITDA
92
88
87
78
71
45
39
79
-15
-472
Interest Expense
12
12
13
13
13
18
19
18
18
21
Depreciation
3
3
3
30
30
36
35
37
37
37
Income Before Tax
29
3
18
28
-5
-15
-20
22
-30
-530
Income Tax Expense
5
0
0
9
-1
-2
-9
3
-4
-46
Net Income
24
4
19
19
-3
-12
-10
19
-25
-484
Net Profit Margin
6.36%
1.10%
5.10%
5.00%
-0.89%
-2.97%
-2.81%
4.39%
-6.61%
-116.47%

Integra Lifesciences Holdings Corp Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
882
992
1,188
1,472
1,517
1,371
1,542
1,557
1,541
1,610
Gross Profit
556
642
752
900
952
851
944
970
888
882
Operating Income
79
115
44
110
178
151
197
238
111
28
EBITDA
195
231
135
241
231
267
366
391
274
193
Interest Expense
23
25
35
64
53
71
50
49
51
70
Depreciation
-
-
88
110
109
116
16
118
123
140
Income Before Tax
60
90
11
57
60
93
214
213
81
-18
Income Tax Expense
53
15
-53
-3
9
-40
45
33
13
-11
Net Income
-3
74
64
60
50
133
169
180
67
-6
Net Profit Margin
-0.40%
7.52%
5.45%
4.13%
3.31%
9.76%
10.96%
11.59%
4.39%
-0.43%

Integra Lifesciences Holdings Corp Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
4
19
19
-3
-12
-10
19
-25
-484
Operating Cash Flow
28
26
58
15
40
22
50
-11
-2
Investing Cash Flow
-15
-7
-57
-53
-322
-10
-4
-35
-57
Financing Cash Flow
-10
-49
-6
358
-93
-19
-7
35
14
Change in Cash
1
-344
2
315
-376
0
31
-7
-28

Integra Lifesciences Holdings Corp Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
74
64
60
50
133
169
180
67
-6
Operating Cash Flow
116
114
199
373
203
312
264
139
129
Investing Cash Flow
-42
-1,221
-49
-304
-68
-161
-58
-94
-390
Financing Cash Flow
-15
1,168
-180
64
121
-98
-251
-229
237
Change in Cash
53
72
-36
60
271
43
-56
-180
-30

Global Institutional Holdings in Integra Lifesciences Holdings Corp

Funds
Holdings
BlackRock Inc
13.78%
Vanguard Group Inc
9.65%
Morgan Stanley - Brokerage Accounts
6.17%
Rubric Capital Management LP
5.96%
Fuller & Thaler Asset Management Inc
5.03%

Insights on Integra Lifesciences Holdings Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 382.65M → 415.60M (in $), with an average increase of 7.9% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Boston Scientific Corp. has given 137.4% return, outperforming this stock by 204.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Boston Scientific Corp. has given 19.9% return, outperforming this stock by 33.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, IART stock has moved down by -35.9%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 19.43M → -484.07M (in $), with an average decrease of 1022.0% per quarter

About Integra Lifesciences Holdings Corp

integra lifesciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. integra's orthopedic products include devices and implants for spine, foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. in the united states, integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. founded in 1989 integra is headquartered in plainsboro, new jersey and has over 3,500 employees worldwide. integra's common stock is li
OrganisationIntegra Lifesciences Holdings Corp
Headquarters1100 Campus Road, Princeton, NJ, United States, 08540
IndustryHealth Technology
CEOMs. Mojdeh Poul
E-voting on sharesClick here to vote

Key Management of Integra Lifesciences Holdings Corp

Name

Title

Ms. Lea Daniels Knight

Executive VP & CFO

Mr. Robert T. Davis Jr.

Executive VP & President of Tissue Technologies

Mr. Michael J. McBreen

Executive VP & President of Codman Specialty Surgical

Mr. Harvinder Pal Singh

Executive VP & President of International Business

Mr. Jeffrey A. Mosebrook

Senior VP of Finance & Principal Accounting Officer

Dr. Stuart M. Essig Ph.D.

Non- Executive Chairman

Mr. Stephen Leonard

Corporate VP of Global Operations & Supply Chain

Christopher Ward

Senior Director of Investor Relations

Laurene Isip

Vice President of Global Corporate Communications & Public Relations

Ms. Mojdeh Poul

President, CEO & Director

FAQs

What is Integra Lifesciences Holdings Corp share price today?

Integra Lifesciences Holdings Corp share price today is $14.81 as on at the close of the market. Integra Lifesciences Holdings Corp share today touched a day high of $15.69 and a low of $14.76.

What is the 52 week high and 52 week low for Integra Lifesciences Holdings Corp share?

Integra Lifesciences Holdings Corp share touched a 52 week high of $27.13 on and a 52 week low of $11.06 on . Integra Lifesciences Holdings Corp stock price today i.e. is closed at $14.81,which is 45.41% down from its 52 week high and 33.91% up from its 52 week low.

What is Integra Lifesciences Holdings Corp's market capitalisation today?

Integra Lifesciences Holdings Corp market capitalisation is $0.00T as on .

How to invest in Integra Lifesciences Holdings Corp Stock (IART) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Integra Lifesciences Holdings Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Integra Lifesciences Holdings Corp Shares that will get you 0.1013 shares as per Integra Lifesciences Holdings Corp share price of $14.81 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Integra Lifesciences Holdings Corp Stock (IART) from India?

Indian investors can start investing in Integra Lifesciences Holdings Corp (IART) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Integra Lifesciences Holdings Corp stock (as per the Rupee-Dollar exchange rate as on ). Based on Integra Lifesciences Holdings Corp share’s latest price of $14.81 as on September 18, 2025 at 1:29 am IST, you will get 0.6752 shares of Integra Lifesciences Holdings Corp. Learn more about fractional shares .

What are the returns that Integra Lifesciences Holdings Corp has given to Indian investors in the last 5 years?

Integra Lifesciences Holdings Corp stock has given -68.14% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?